Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses

Sian Jossi, Melissa Arcuri, Areej Alshayea, Ruby Persaud, Edith Marcial Juarez, Elena Palmieri, Roberta Di Benedetto, Marisol Perez-Toledo, Jamie Pillaye, Will Channell, Anna Schager, Rachel Lamerton, Charlie Jones, Margaret Goodall, Takeshi Haneda, Andreas J. Bäumler, Lucy H. Jackson-Jones, Kai Toellner, Calman MacLennan, Ian HendersonFrancesca Micoli, Adam Cunningham^*

^*Corresponding author for this work

Immunology and Immunotherapy

Research output: Contribution to journal › Article › peer-review

66 Downloads (Pure)

1 results

Filter

Finished
FP7_MC_ITN-VADER
Henderson, I., Cunningham, A. & Gough, R.
European Commission, European Commission - Management Costs
1/10/12 → 30/09/16
Project: Research

Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses

Projects

Search results

FP7_MC_ITN-VADER